MediWound (MDWD) director Rubinstein reports options and share holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
MediWound Ltd. director Samuel Rubinstein filed an initial Form 3 reporting his equity holdings in the company. He holds stock options over 7,200, 7,542, 5,600 and 6,250 ordinary shares at exercise prices of $9.6400, $12.7290, $18.5400 and $17.6000, expiring between 2033 and 2036. He also holds 2,843 and 750 ordinary shares directly, plus 525 ordinary shares held indirectly by his spouse. Footnotes state that certain ordinary shares are underlying RSUs granted on March 4, 2026, and certain options were also granted on that date, with each grant vesting 100% on the one-year anniversary of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Rubinstein Samuel
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy ordinary shares) — 7,200 shares (Direct);
Ordinary shares — 2,843 shares (Direct);
Ordinary shares — 525 shares (Indirect, By spouse)
Footnotes (1)
- The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date. The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
FAQ
What does the MediWound (MDWD) Form 3 by Samuel Rubinstein report?
The Form 3 reports Rubinstein’s initial ownership in MediWound. It details his stock options over multiple ordinary share blocks, direct ordinary share holdings, and additional shares held indirectly through his spouse, establishing his baseline equity position as a company director.
What stock options does Samuel Rubinstein hold in MediWound (MDWD)?
Rubinstein holds options to buy ordinary shares at exercise prices of $9.6400, $12.7290, $18.5400 and $17.6000. These option grants cover blocks of 7,200, 7,542, 5,600 and 6,250 underlying ordinary shares and expire between 2033 and 2036.
How are RSUs and option vesting described in the MediWound (MDWD) Form 3?
Footnotes explain that certain ordinary shares are underlying RSUs granted on March 4, 2026, vesting 100% one year after that date. Other options granted on the same day also vest 100% on the one-year anniversary, indicating a cliff-vesting structure for these equity awards.
Does the MediWound (MDWD) Form 3 show any insider buying or selling activity?
The Form 3 records holdings rather than transactions, so it does not show buys or sells. All entries are reported as positions in stock options, ordinary shares, and indirect holdings, establishing Rubinstein’s initial ownership status as a director at the reporting date.
What are the expiration dates for Rubinstein’s MediWound (MDWD) stock options?
His reported option grants expire on August 15, 2033, February 26, 2034, February 11, 2035, and March 4, 2036. These long-dated expirations indicate multi-year potential exercise windows tied to MediWound’s ordinary shares.